相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Virus-like particles for vaccination against cancer
Mona O. Mohsen et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
Bacteriophage MS2 displays unreported capsid variability assembling T=4 and mixed capsids
Natalia de Martin Garrido et al.
MOLECULAR MICROBIOLOGY (2020)
Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch
Florian Olomski et al.
ALLERGY (2020)
Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density
Connie B. Gilfillan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens
Federico Storni et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Vaccination against Allergy: A Paradigm Shift?
Martin F. Bachmann et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis
Isabell S. von Loga et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects
Franziska Thoms et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer (vol 7, 114, 2019)
Mona O. Mohsen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Mapping spheroid rotation modes in turbulent channel flow: effects of shear, turbulence and particle inertia
Lihao Zhao et al.
JOURNAL OF FLUID MECHANICS (2019)
Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses
Mark K. Slifka et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine
Mona O. Mohsen et al.
FRONTIERS IN IMMUNOLOGY (2019)
RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion
Caroline C. Krueger et al.
FRONTIERS IN IMMUNOLOGY (2019)
Type of RNA Packed in VLPs Impacts IgG Class Switching-Implications for an Influenza Vaccine Design
Ariane C. Gomes et al.
VACCINES (2019)
Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection
Gustavo Cabral-Miranda et al.
VACCINES (2019)
Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands-A Role for CCL2
Ariane C. Gomes et al.
FRONTIERS IN IMMUNOLOGY (2019)
Virus-Specific Secondary Plasma Cells Produce Elevated Levels of High-Avidity Antibodies but Are Functionally Short Lived
Caroline C. Krueger et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies
Hanne L. P. Tytgat et al.
NATURE COMMUNICATIONS (2019)
Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses
Antonia Fettelschoss-Gabriel et al.
ALLERGY (2019)
Immunogenicity, safety and tolerability of intradermal influenza vaccines
Ivan F. N. Hung et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Vaccination against IL-31 for the treatment of atopic dermatitis in dogs
Martin F. Bachmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
Young-Tae Lee et al.
PLOS ONE (2018)
Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine
David A. G. Skibinski et al.
SCIENTIFIC REPORTS (2018)
Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
Ludger Klimek et al.
ALLERGO JOURNAL (2018)
Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells
P. Engeroff et al.
ALLERGY (2018)
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination
Mona O. Mohsen et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
Marika Doucet et al.
PLOS ONE (2017)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines
Ariane C. Gomes et al.
FRONTIERS IN IMMUNOLOGY (2017)
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergy
Andris Zeltins et al.
NPJ VACCINES (2017)
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
P. H. Lizotte et al.
NATURE NANOTECHNOLOGY (2016)
Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
Claudia Cavelti-Weder et al.
MOLECULAR THERAPY (2016)
Preparation and evaluation of MS2 bacteriophage-like particles packaging hepatitis E virus RNA
Shen Wang et al.
FEMS MICROBIOLOGY LETTERS (2016)
Polio vaccination: past, present and future
Ananda S. Bandyopadhyay et al.
FUTURE MICROBIOLOGY (2015)
Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques
Frank Liang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Encapsidation of Host RNAs by Cucumber Necrosis Virus Coat Protein during both Agroinfiltration and Infection
Kankana Ghoshal et al.
JOURNAL OF VIROLOGY (2015)
The Interface between Hepatitis B Virus Capsid Proteins Affects Self-Assembly, Pregenomic RNA Packaging, and Reverse Transcription
Zhenning Tan et al.
JOURNAL OF VIROLOGY (2015)
The prevention and eradication of smallpox: a commentary on Sloane (1755) 'An account of inoculation'
Robin A. Weiss et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV
Ethan Poteet et al.
PLOS ONE (2015)
Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies
Franziska Zabel et al.
JOURNAL OF IMMUNOLOGY (2014)
Yeast-Expressed Bacteriophage-Like Particles for the Packaging of Nanomaterials
Janis Freivalds et al.
MOLECULAR BIOTECHNOLOGY (2014)
Safety and immunogenicity of a virus-like, particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers
Jenny G. H. Low et al.
VACCINE (2014)
Preclinical efficacy and safety of an anti-IL-1 beta vaccine for the treatment of type 2 diabetes
Gunther Spohn et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications
Nicolas J. Pillon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Mechanisms of action of adjuvants
Sunita Awate et al.
FRONTIERS IN IMMUNOLOGY (2013)
Developments in rabies vaccines
D. J. Hicks et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+ T-cell responses in melanoma patients
Simone M. Goldinger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen
Alexander Link et al.
JOURNAL OF IMMUNOLOGY (2012)
Analysis of the size of DNA packaged by the human JC virus-like particle
Chiung-Yao Fang et al.
JOURNAL OF VIROLOGICAL METHODS (2012)
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
Bengt Winblad et al.
LANCET NEUROLOGY (2012)
Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41
C. Pastori et al.
VIROLOGY (2012)
CpG DNA as a vaccine adjuvant
Christian Bode et al.
EXPERT REVIEW OF VACCINES (2011)
The Second-Generation Active Aβ Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
Christoph Wiessner et al.
JOURNAL OF NEUROSCIENCE (2011)
Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation
Susanne A. Keller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
T Cell-dependent and -Independent IgA Responses: Role of TLR Signalling
Juliana Bessa et al.
IMMUNOLOGICAL INVESTIGATIONS (2010)
Cutting Edge: IL-21 and TLR Signaling Regulate Germinal Center Responses in a B Cell-Intrinsic Manner
Juliana Bessa et al.
JOURNAL OF IMMUNOLOGY (2010)
Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
Daniel E. Speiser et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses
Juliana Bessa et al.
JOURNAL OF IMMUNOLOGY (2009)
Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes
Rafael Cubas et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Assembly of mixed rod-like and spherical particles from group I and II RNA bacteriophage coat proteins
Janis Rumnieks et al.
VIROLOGY (2009)
Representation of viruses in the remediated PDB archive
Catherine L. Lawson et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2008)
Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope
Andris Kazaks et al.
Biotechnology Journal (2008)
Nanoparticles target distinct dendritic cell populations according to their size
Vania Manolova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Evidence based route of administration of vaccines
I. F. Cook
HUMAN VACCINES (2008)
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure:: a double-blind, randomised, placebo-controlled phase IIa study
Alain C. Tissot et al.
LANCET (2008)
Vaccination against nicotine: an emerging therapy for tobacco dependence
Patrik Maurer et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Copper-free click chemistry for dynamic in vivo imaging
Jeremy M. Baskin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Expression of chemokine receptors in insulin-resistant human skeletal muscle cells
H. Sell et al.
HORMONE AND METABOLIC RESEARCH (2007)
TLR9 signaling in B cells determines class switch recombination to IgG2a
Andrea Jegerlehner et al.
JOURNAL OF IMMUNOLOGY (2007)
Designing recombinant vaccines with viral properties: A rational approach to more effective vaccines
Gary T. Jennings et al.
CURRENT MOLECULAR MEDICINE (2007)
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Thomas M. Kuendig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Modified Tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
Mark L. Smith et al.
VIROLOGY (2006)
Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles
K Schwarz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects
T Storni et al.
JOURNAL OF IMMUNOLOGY (2004)
In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway
VG Morón et al.
JOURNAL OF IMMUNOLOGY (2003)
Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles
T Storni et al.
JOURNAL OF IMMUNOLOGY (2002)
Mutilation of RNA phage Qβ virus-like particles:: from icosahedrons to rods
I Cielens et al.
FEBS LETTERS (2000)